No abstract available
MeSH terms
-
Adenine / analogs & derivatives
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Bridged Bicyclo Compounds, Heterocyclic / therapeutic use
-
Clinical Trials as Topic
-
Cyclophosphamide / administration & dosage
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Neoplasm Proteins / antagonists & inhibitors
-
Patient Selection
-
Piperidines
-
Progression-Free Survival
-
Protein Kinase Inhibitors / therapeutic use
-
Pyrazoles / therapeutic use
-
Pyrimidines / therapeutic use
-
Rituximab / administration & dosage
-
Sulfonamides / therapeutic use
-
Treatment Outcome
-
Vidarabine / administration & dosage
-
Vidarabine / analogs & derivatives
Substances
-
Bridged Bicyclo Compounds, Heterocyclic
-
Neoplasm Proteins
-
Piperidines
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Pyrimidines
-
Sulfonamides
-
ibrutinib
-
Rituximab
-
Cyclophosphamide
-
Vidarabine
-
Adenine
-
venetoclax
-
fludarabine